NCT01667575View on ClinicalTrials.gov

Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Functional DyspepsiaPeptic UlcerHelicobacter Pylori
Interventions
DRUG

Esomeprazole

antisecretary drug of the quadruple therapy

DRUG

Amoxicillin

antibiotic of the quadruple therapy

DRUG

Clarithromycin

antibiotic of the quadruple therapy

DRUG

Bismuth Potassium Citrate

one of a component of a quadruple therapy

OTHER

long duration (14 day)

Trial Locations (1)

200127

Renji Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Jiao Tong University School of Medicine

OTHER

NCT01667575 - Efficiency Study of Clarithromycin and Bismuth-containing Quadruple Therapy to Treat H.Pylori | Biotech Hunter | Biotech Hunter